258 related articles for article (PubMed ID: 15094591)
1. [Management of ductal carcinoma in situ by the pathologist: current questions].
Arnould L; Caron Y; Sigal-Zafrani B
Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
[TBL] [Abstract][Full Text] [Related]
2. [Node status in 454 ductal breast cancers cases according to the association with in situ component].
Carabias-Meseguer P; Cusidó-Gimferrer M; Zapardiel-Gutiérrez I; Tresserra-Casas F; Fábregas-Xauradó R; Xercavins-Montoya J
Ginecol Obstet Mex; 2011 Jan; 79(1):5-10. PubMed ID: 21966777
[TBL] [Abstract][Full Text] [Related]
3. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic immunohistochemistry of breast epithelial lesions].
Balaton AJ; Guinebretière JM; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):570-81. PubMed ID: 15094595
[TBL] [Abstract][Full Text] [Related]
5. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.
Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA
J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190
[TBL] [Abstract][Full Text] [Related]
6. [Diseases of the female breast: clinical pathology].
Torhorst J
Ther Umsch; 1993 May; 50(5):307-13. PubMed ID: 8397447
[TBL] [Abstract][Full Text] [Related]
7. Borderline breast lesions: diagnostic challenges and clinical implications.
Masood S; Rosa M
Adv Anat Pathol; 2011 May; 18(3):190-8. PubMed ID: 21490436
[TBL] [Abstract][Full Text] [Related]
8. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
Bofin AM; Lydersen S; Hagmar BM
Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
[TBL] [Abstract][Full Text] [Related]
9. Definition of precancerous and high-risk mammary lesions.
Bégin LR
Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
[TBL] [Abstract][Full Text] [Related]
10. [Breast cancer from the viewpoint of the pathologist].
Reiner A
Wien Med Wochenschr; 2000; 150(4):58-62. PubMed ID: 10829305
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
[TBL] [Abstract][Full Text] [Related]
12. [Morphological diagnosis and prognosis in early ductal breast cancer].
Frank GA; Volchenko NN
Vopr Onkol; 1992; 38(3):299-310. PubMed ID: 1338666
[TBL] [Abstract][Full Text] [Related]
13. Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit.
Moore KH; Sweeney KJ; Wilson ME; Goldberg JI; Buchanan CL; Tan LK; Liberman L; Turner RR; Lagios MD; Cody Iii HS; Giuliano AE; Silverstein MJ; Van Zee KJ
Ann Surg Oncol; 2007 Oct; 14(10):2911-7. PubMed ID: 17597346
[TBL] [Abstract][Full Text] [Related]
14. Nonpalpable breast lesions: wire localization and excisional biopsy.
Proudfoot RW; Mattingly SS; Stelling CB; Fine JG
Am Surg; 1986 Mar; 52(3):117-22. PubMed ID: 3006562
[TBL] [Abstract][Full Text] [Related]
15. Breast carcinogenesis. Transition from hyperplasia to invasive lesions.
Meteoglu I; Dikicioglu E; Erkus M; Culhaci N; Kacar F; Ozkara E; Uyar M
Saudi Med J; 2005 Dec; 26(12):1889-96. PubMed ID: 16380768
[TBL] [Abstract][Full Text] [Related]
16. In situ carcinomas of the female breast. Diagnostic and therapeutic aspects with special reference to histological growth patterns. Clinical review.
Blichert-Toft M; Andersen J; Dyreborg U
Acta Chir Scand; 1990 Feb; 156(2):113-9. PubMed ID: 2158737
[TBL] [Abstract][Full Text] [Related]
17. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
18. Mammary endocrine ductal carcinoma in situ: a case report.
Danikas D; Matthews WE; Averbach DJ
Am Surg; 2000 Dec; 66(12):1163-4. PubMed ID: 11149590
[TBL] [Abstract][Full Text] [Related]
19. Management of lobular neoplasia diagnosed by core needle biopsy: study of 52 biopsies with follow-up surgical excision.
Lavoué V; Graesslin O; Classe JM; Fondrinier E; Angibeau H; Levêque J
Breast; 2007 Oct; 16(5):533-9. PubMed ID: 17629481
[TBL] [Abstract][Full Text] [Related]
20. Do breast columnar cell lesions with atypia need to be excised?
Datrice N; Narula N; Maggard M; Butler J; Hsiang D; Baick C; Lane K
Am Surg; 2007 Oct; 73(10):984-6. PubMed ID: 17983063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
